Insidehealthpolicy

Published September 14, 2026 · Updated September 15, 2026

FDA Considers Therapy Aspect Of Psychedelic Mental Health Practice

Read the full story at Insidehealthpolicy

The difficulty of evaluating psychedelic treatments under existing FDA frameworks was in the spotlight at a meeting seeking public feedback on the.